Metabolism of captopril carboxyl ester derivatives for percutaneous absorption

Journal of Pharmacy and Pharmacology

Volumn 61, Issue 2, 2009, Pages 159-165

  Gullick, Darren R ^a   Ingram, Matthew J ^b   Pugh, W John ^c   Cox, Paul A ^a   Gard, Paul ^b   Smart, John D ^c   Moss, Gary P ^d  

^a UNIVERSITY OF PORTSMOUTH   (United Kingdom)

^b UNIVERSITY OF BRIGHTON   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

Author keywords

Autodock; Captopril; Metabolism; Percutaneous absorption; Transdermal drug delivery

Indexed keywords

CAPTOPRIL; CAPTOPRIL CARBOXYL ESTER DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTER DERIVATIVE; PRODRUG; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; DATA ANALYSIS SOFTWARE; DRUG ABSORPTION; DRUG EFFECT; DRUG METABOLISM; ENZYME INHIBITION; NONHUMAN;

EID: 59049099239     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.61.02.0004     Document Type: Article

References (32)

1. Bhandari KH et al. Evaluation of physicochemical properties, skin permeation and accumulation profiles of ketorolac fatty ester prodrugs. Biol Pharm Bull 2007; 30: 2211-2216.
2. Suppasansatorn P et al. Microemulsions as topical delivery vehicles for the anti-melanoma prodrug, temozolomide hexyl ester (TMZA-HE). J Pharm Pharmacol 2007; 59; 787-794.
3. Roberts WJ, Sloan KB. Prediction of transdermal flux of prodrugs of 5-fluorouracil, theophylline, and 6-mercaptopurine with a series/parallel model. J Pharm Sci 2000; 89: 1415-1431.
4. Hammell DC et al. A duplex "Gemini" prodrug of naltrexone for transdermal delivery. J Control Release 2004; 97: 283-290.
5. Wang JJ et al. Ester prodrugs of morphine improve transdermal drug delivery: a mechanistic study. J Pharm Pharmacol 2007; 59: 917-925.
6. Burris JF. The USA experience with the clonidine transdermal therapeutic system. Clin Auton Res 1993; 3: 391.
7. Moss GP et al. Design, synthesis and characterization of captopril prodrugs for enhanced percutaneous absorption. J Pharm Pharmacol 2006; 58: 167-177.
8. Pannatier A et al. The skin as a drug-metabolizing organ. Drug Metab Rev 1978; 8: 319-343.
9. Mukhtar H, Bickers DR. Drug metabolism in skin. Comparative activity of the mixed-function oxidases, epoxide hydratase, and glutathione S-transferase in liver and skin of the neonatal rat. Drug Metab Dispos 1981; 9: 311-314.
10. Ahmed S et al. Evaluation of stereoselective transdermal transport and concurrent cutaneous hydrolysis of several ester prodrugs of propranolol: mechanism of stereoselective permeation. Pharm Res 1996; 13: 1524-1529.
11. Stinchcomb AL et al. Straight-chain naltrexone ester prodrugs: diffusion and concurrent esterase biotransformation in human skin. J Pharm Sci 2002; 91: 2571-2578.
12. Ngawhirunpat T et al. Evaluation of simultaneous permeation and metabolism of methyl nicotinate in human, snake, and shed snake skin. Pharm Dev Technol 2008; 13: 75-83.
13. Jewell C et al. The distribution of esterases in the skin of the minipig. Toxicol Lett 2007; 173: 118-123.
14. Abdulmajed K et al. Topical delivery of retinyl ascorbate co-drug. 5. In vitro degradation studies. Skin Pharmacol Physiol 2006; 19: 248-258.
15. Suppasansatorn P et al. Skin delivery potency and antitumor activities of temozolomide ester prodrugs. Cancer Lett 2006; 244: 42-52.
16. Prusakiewicz JJ et al. Comparison of skin esterase activities from different species. Pharm Res 2006; 23: 1517-1524.
17. Henrikus BM, Kampffmeyer HG. Ester hydrolysis and conjugation reactions in intact skin and skin homogenate, and by liver esterase of rabbits. Xenobiotica 1992; 22: 1357-1366.
18. British Pharmacopeia. Captopril monograph. In: British Pharmacopoeia. London: HMSO, 2003: 324-325.
19. Woolfson AD et al. The metabolism of amethocaine by porcine and human skin extracts: influence on percutaneous anaesthesia. Int J Pharm 1990; 62: 9.
20. Gasteiger J, Marsili M. A new model for calculating atomic charges in molecules. Tetrahedron Lett 1978; 19: 3181-3184.
21. Zar JH. Comparing simple linear equations. In: Zar JH, ed. Biostatistical Analysis, 4th edn. Upper Saddle River, NJ: Prentice Hall, 1999: 360-376.
22. Doh HJ et al. Synthesis and evaluation of ketorolac ester prodrugs for transdermal delivery. J Pharm Sci 2003; 92: 1008-1017.
23. Seki T et al. Enhanced delivery of zidovudine through rat and human skin via ester prodrugs. Pharm Res 1990; 7: 948-952.
24. Goodsell DS et al. Automated docking of flexible ligands: applications of AutoDock. J Mol Recognit 1996; 9: 1-5.
25. Cruciani G et al. MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist. J Med Chem 2005; 48: 6970-6979.
26. Cheung YW et al. Cutaneous biotransformation as a parameter in the modulation of the activity of topical corticosteroids. Int J Pharm 1985; 26: 175.
27. Bonina FP et al. In vitro and in vivo evaluation of polyoxyethylene esters as dermal prodrugs of ketoprofen, naproxen and diclofenac. Eur J Pharm Sci 2001; 14: 123-134.
28. Kim BY et al. Ketorolac amide prodrugs for transdermal delivery: stability and in vitro rat skin permeation studies. Int J Pharm 2005; 293: 193-202.
29. Bickers DR et al. Epidermis: a site of drug metabolism in neonatal rat skin. Studies on cytochrome P-450 content and mixed-function oxidase and epoxide hydrolase activity. Mol Pharmacol 1982; 21: 239-247.
30. Yamaguchi K et al. Analysis of in vitro skin permeation of 22-oxacalcitriol having a complicated metabolic pathway. Pharm Res 2006; 23: 680-688.
31. Wester RC et al. Variations in percutaneous absorption of testosterone in the rhesus monkey due to anatomic site of application and frequency of application. Arch Dermatol Res 1980; 267: 229-235.
32. Ganong WF. Reproduction and the renin-angiotensin system. Neurosci Biobehav Rev 1995; 19: 241.